These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 36175174)
1. Daily dynamics of negative affect: indicators of rate of response to treatment and remission from depression? Helmich MA; Wichers M; Peeters F; Snippe E Cogn Emot; 2022 Dec; 36(8):1594-1604. PubMed ID: 36175174 [TBL] [Abstract][Full Text] [Related]
2. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
3. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores. Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208 [TBL] [Abstract][Full Text] [Related]
4. Affective dynamics in bipolar spectrum psychopathology: Modeling inertia, reactivity, variability, and instability in daily life. Sperry SH; Kwapil TR J Affect Disord; 2019 May; 251():195-204. PubMed ID: 30927580 [TBL] [Abstract][Full Text] [Related]
5. Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Geschwind N; Nicolson NA; Peeters F; van Os J; Barge-Schaapveld D; Wichers M Eur Neuropsychopharmacol; 2011 Mar; 21(3):241-7. PubMed ID: 21146375 [TBL] [Abstract][Full Text] [Related]
6. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? Zimmerman M; Martinez JA; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M J Clin Psychiatry; 2012 Jun; 73(6):790-5. PubMed ID: 22569085 [TBL] [Abstract][Full Text] [Related]
7. Affect Dynamics as Predictors of Symptom Severity and Treatment Response in Mood and Anxiety Disorders: Evidence for Specificity. Bosley HG; Soyster PD; Fisher AJ J Pers Oriented Res; 2019; 5(2):101-113. PubMed ID: 33569146 [TBL] [Abstract][Full Text] [Related]
8. Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder. Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Schoevers RA; Denys D; Ruhé HG; van Wingen GA J Affect Disord; 2022 Aug; 310():156-161. PubMed ID: 35490877 [TBL] [Abstract][Full Text] [Related]
9. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy. Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814 [TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder. Jakobsen JC Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628 [TBL] [Abstract][Full Text] [Related]
11. Real-world affect and social context as predictors of treatment response in child and adolescent depression and anxiety: an ecological momentary assessment study. Forbes EE; Stepp SD; Dahl RE; Ryan ND; Whalen D; Axelson DA; Birmaher B; Silk JS J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):37-47. PubMed ID: 22339611 [TBL] [Abstract][Full Text] [Related]
12. The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome. Hernandez CR; Smith GS; Houck PR; Pollock BG; Mulsant B; Dew MA; Reynolds CF Psychiatry Res; 2000 Dec; 97(1):41-9. PubMed ID: 11104856 [TBL] [Abstract][Full Text] [Related]
13. Negative affect instability predicts elevated depressive and generalized anxiety disorder symptoms even when negative affect intensity is controlled for: an ecological momentary assessment study. Sultson H; Murd C; Havik M; Konstabel K Front Psychol; 2024; 15():1371115. PubMed ID: 38716268 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression. Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010 [TBL] [Abstract][Full Text] [Related]
17. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782 [TBL] [Abstract][Full Text] [Related]
18. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial. Callesen P; Reeves D; Heal C; Wells A Sci Rep; 2020 May; 10(1):7878. PubMed ID: 32398710 [TBL] [Abstract][Full Text] [Related]
19. The remission from depression questionnaire as an outcome measure in the treatment of depression. Zimmerman M; Martinez JH; Attiullah N; Friedman M; Toba C; Boerescu DA Depress Anxiety; 2014 Jun; 31(6):533-8. PubMed ID: 24115164 [TBL] [Abstract][Full Text] [Related]
20. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data. Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]